Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |